Contact this trialFirst, we need to learn more about you.
Stem Cell Transplant
Stem Cell Transplant with T-allo10 Addback for Blood Diseases
Recruiting1 awardPhase 1
Palo Alto, California
This trial is studying a cell therapy called T-allo10 given after a stem cell transplant in order to help with the adaptive immune reconstitution while sparing the risk of developing severe Graft-versus-Host Disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service